The clinical nutrition market size is projected to be valued at US$ 13.4 billion in 2023 and is expected to rise to US$ 29.2 billion by 2033. The sales of clinical nutrition are expected to expand at a significant CAGR of 8.1% during the forecast period.
Various Factors Propelling the Demand for Clinical Nutrition are:
The connection between nutrition and well-being is gaining traction due to the increase in life expectancy. people are more aware of the risks that can affect their lifespans (cardiovascular diseases, diabetes, and cancer) and focus more attention on longevity.
It is commonly acknowledged that a balanced diet promotes healthy aging and nutrition is becoming a more important factor in choosing a healthy lifestyle.
Numerous physiological changes that can lead to frailty, appetite loss, decreased bone and muscle mass, and a compromised immune system marks the beginning of premature aging. The nutritional needs of individuals, who are frequently affected by malnutrition and a variety of other illnesses, are supported by clinical nutrition.
The upsurge in mortality rates in developing economies as well as advancements in the home healthcare industry are driving up demand for home enteral formulae. Another factor encouraging the incorporation of clinical nutrition and dietetics is the emergence of favorable reimbursement policies.
The clinical nutrition offerings are less of a health concern now. The availability of clinical nutrition products is significantly expanding, and they can now be bought outside of pharmacies as ready-to-eat meals and everyday snacks as well as powders or supplements.
The idea of healthy aging is becoming more popular, and there are more nutritional products available, therefore there is always going to be a demand for a wide variety of nutritional items.
The threat posed by counterfeit products may be a significant obstacle for the clinical nutrition market. These fake goods are subpar or could endanger customers' safety and the brand's reputation.
Additionally, the emergence of organized distribution channels, such as supermarkets, hypermarkets, grocery stores, convenience stores, and department stores, is providing manufacturers with lucrative growth potential.
| Attribute | Details |
|---|---|
| Market Estimated Size (2023) | US$ 13.4 billion |
| Market CAGR (2023 to 2033) | 8.1% |
| Market Forecasted Size (2033) | US$ 29.2 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Market to witness an absolute dollar growth of US$ 15.8 billion between comparison periods. The Covid-19 virus had negative health effects, but it also generated awareness among adults and especially the elderly, more aware of their fragility and attentive to their dietary needs. The concept of healthy aging and taking into account the elderly may be the issues that businesses are expected to be confronting more than ever in the years to come due to the aging population growing high.
Healthcare infrastructure, which makes use of clinical nutrition, is getting increasingly advanced in highly industrialized nations with high chronic illness prevalence. Medical nutrition becomes increasingly personalized, just like other areas of health and wellness, due to the developments like formulae for specific conditions (including Crohn's disease, Alzheimer's disease, and post-surgery rehabilitation).
Considering this, FMI expects global animal healthcare to expand at a CAGR of 8.1% from 2023 to 2033.
Opportunities Abound in the New Product Launches
People suffering from metabolic disorders such as diabetes are at high risk of acquiring COVID-19 infection. According to the International Diabetes Federation, people with pre-existing medical conditions such as diabetes and obesity are more prone to be infected with the SARS-CoV-2 virus due to compromised immune systems in these individuals.
Treating diabetic patients infected with COVID-19 is a bit difficult as the virus tends to grow immensely in elevated blood sugar levels. Controlling blood sugar levels is of utmost importance in treating COVID-19-infected patients. Thus, nutritional support plays a vital role in this context, thereby aiding in the segment's growth.
The rising burden of metabolic disorders also increases the demand for clinical nutrition. According to International Diabetes Federation, about over 425 million people live with diabetes, and this number is expected to reach 700 million in 2045. Hence, the increasing burden of metabolic disorders and the introduction of new products to the market are expected to fuel this segment. Also, the growing product launches are expected to propel market growth. For instance, as a result, in February 2020, Galen launched an innovative medical food PKU EASY Microtabs, for people living with the rare, inherited metabolic disorder phenylketonuria (PKU).
One of the primary reasons that are likely to have a big impact on the overall growth of the worldwide clinical nutrition products market in the next years is changing consumer patterns in terms of diet and consumption of various nutritional goods.
The growing prevalence of lifestyle diseases is affecting a prominent share of the population. Adults are more prone to them due to their hectic lifestyles and imbalanced nutrition. Increasing cases of metabolic issues among adults have shifted their preference for clinical nutrition. The use of the proper supplements, such as vitamins, minerals, and other nutrients, helps the body's metabolic system to heal. The rising population that requires treatment for malnutrition further provides immense opportunities for the market to grow.
The High Prevalence of Cancer Around the World Creates the Need for Proper Nutrition
Based on application, cancer is leading the growth trajectory with a CAGR of 7.6%. One in six, fatalities worldwide is caused by cancer, which is the second leading cause of death worldwide. Patients with cancer and those suffering from chronic disease, are at risk of malnutrition. Malnutrition is a danger for patients taking Covid-19, especially the elderly and those with chronic illnesses. To avoid nutritional deficiencies and muscle loss while in the hospital, these patients need nutritional support during their therapy. A person's "health capital" is developed through proper eating, making them more resilient in the face of emergency cases and less vulnerable to illness. In this regard, the diet has a part to play in reducing the further risks associated with improper nutrition to develop immunity.
Principal Consultant
The United Kingdom is Witnessing Strong Growth due to the Expansion of Nutrition Centers Across the Region
With the rise in preterm births and the continued prevalence of chronic diseases nationwide, the United Kingdom is predicted to experience high consumption of clinical nutrition products. The rising elderly population base and the ongoing usage of home enteral feeding systems might boost the regional market. Additionally, there has been an increase in the prevalence of gastrointestinal, viral, and metabolic problems, which is expected to favorably affect the establishment of clinical nutrition centers across the United Kingdom.
| The United Kingdom Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 1.1 billion |
|---|---|
| The United Kingdom Market Absolute Dollar Growth (US$ million/billion) | US$ 562.3 million |
| CAGR % 2017 to 2022 | 3.7% |
| CAGR % 2023 to 2033 | 7.2% |
The United States Holds a Controlled Share of the Market Due to its Highly Developed Healthcare Industry
The demand for clinical nutrition has increased in the United States as a result of the senior population's growing health problems. According to the Centers for Disease Control (CDC), nearly 35% of children in America regularly consume junk food, which puts them at risk for developing obesity, diabetes, and cardiovascular problems. This may further increase the market's need for clinical nutrition. The United States government's initiative to support comprehensive nutrition care for cancer patients is also a factor in the expansion of the clinical nutrition industry.
| The United States Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 9.4 billion |
|---|---|
| US Market Absolute Dollar Growth (US$ million/billion) | US$ 5.0 billion |
| CAGR % 2017 to 2022 | 4.6% |
| CAGR % 2023 to 2033 | 7.9% |
The high Prevalence of the Elderly Population in the Asia Pacific Region Gives a Significant Room for Market Development
The main causes of the expansion include an increase in malnutrition-related illnesses, an increase in metabolic disorders, a growth in patient awareness of clinical nutritional products, and an increase in the number of elderly people. The prevalence of diabetes is also increasing significantly in China, according to research by the world hunger education service. Diabetes is a serious problem for obesity and is driving up demand for clinical nutrition products. By 2050, there may be three times as many elderly people living in the Asia Pacific region as there are today, according to research by UNFPA (United Nations Fund for Population Activities Asia and Pacific).
| China Market Size (US$ million/billion) by End of Forecast Period (2033) | US$ 2.8 billion |
|---|---|
| China Market Absolute Dollar Growth (US$ million/billion) | US$ 1.5 billion |
| CAGR % 2017 to 2022 | 4.3% |
| CAGR % 2023 to 2033 | 7.5% |
Prominent participants in the clinical nutrition industry include Nestle Health Science, Fresenius Kabi, Abbott Laboratories, Danone, B Braun Melsungen AG, Baxter International Inc., Mead Johnson (Reckitt Benckiser), and Perrigo.
These important stakeholders concentrate on strategic initiatives including collaborations, alliances, the launch of new products, and commercialization of the development of the company. Additionally, these market leaders are investing heavily in research to launch fresh items and increase profits.
Latest Developments:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.1% from 2023 to 2033 |
| Base Year of Estimation | 2023 |
| Historical Data | 2017 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in US$ billion and Volume in Units and F-CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, growth factors, Trends, and Pricing Analysis |
| Key Segments Covered | By Product, By Application, By Distribution Channel, By Consumer, By Region |
| Regions Covered | North America; Latin America; Europe; East Asia; South Asia; The Middle East & Africa; Oceania |
| Key Countries Profiled | Unite States, Canada, Brazil, Mexico, Germany, Italy, France United Kingdom, Spain, Russia, China, Japan, India, GCC Countries, Australia |
| Key Companies Profiled | Nestle Health Science, Fresenius Kabi, Abbott Laboratories, Danone, B Braun Melsungen AG, Baxter International Inc., Mead Johnson (Reckitt Benckiser), and Perrigo. |
| Customization & Pricing | Available upon Request |
The global clinical nutrition market is estimated to be valued at US$ 13.4 billion in 2023.
The clinical nutrition market is likely to expand at a CAGR of 8.1% from 2023 to 2033.
The clinical nutrition market is projected to reach a valuation of US$ 29.2 billion by 2033.
North America is projected to lead the global clinical nutrition market by 2033.
1. Executive Summary | Clinical Nutrition Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Consumer
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Consumer, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Consumer, 2023 to 2033
5.3.1. Pediatric
5.3.2. Adult
5.4. Y-o-Y Growth Trend Analysis By Consumer, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Consumer, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Product, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
6.3.1. Infant Nutrition
6.3.2. Enteral Nutrition
6.3.3. Parenteral Nutrition
6.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Application , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application , 2023 to 2033
7.3.1. Cancer
7.3.2. Metabolic Disorders
7.3.3. Neurological Diseases
7.3.4. Gastrointestinal Disorders
7.3.5. Others
7.4. Y-o-Y Growth Trend Analysis By Application , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Application , 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2023 to 2033
8.3.1. Retail Stores
8.3.2. Pharmacies & Drug Stores
8.3.3. Online Channels
8.3.4. Others
8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022
8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Consumer
10.2.3. By Product
10.2.4. By Application
10.2.5. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Consumer
10.3.3. By Product
10.3.4. By Application
10.3.5. By Distribution Channel
10.4. Key Takeaways
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Consumer
11.2.3. By Product
11.2.4. By Application
11.2.5. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Consumer
11.3.3. By Product
11.3.4. By Application
11.3.5. By Distribution Channel
11.4. Key Takeaways
12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. United Kingdom
12.2.1.2. Spain
12.2.1.3. Germany
12.2.1.4. Italy
12.2.1.5. France
12.2.1.6. Rest of Europe
12.2.2. By Consumer
12.2.3. By Product
12.2.4. By Application
12.2.5. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Consumer
12.3.3. By Product
12.3.4. By Application
12.3.5. By Distribution Channel
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. China
13.2.1.3. Japan
13.2.1.4. Australia
13.2.1.5. Rest of Asia Pacific
13.2.2. By Consumer
13.2.3. By Product
13.2.4. By Application
13.2.5. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Consumer
13.3.3. By Product
13.3.4. By Application
13.3.5. By Distribution Channel
13.4. Key Takeaways
14. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. South Africa
14.2.1.2. GCC Countries
14.2.1.3. Rest of Middle East and Africa
14.2.2. By Consumer
14.2.3. By Product
14.2.4. By Application
14.2.5. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Consumer
14.3.3. By Product
14.3.4. By Application
14.3.5. By Distribution Channel
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. USA
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Consumer
15.1.2.2. By Product
15.1.2.3. By Application
15.1.2.4. By Distribution Channel
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Consumer
15.2.2.2. By Product
15.2.2.3. By Application
15.2.2.4. By Distribution Channel
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Consumer
15.3.2.2. By Product
15.3.2.3. By Application
15.3.2.4. By Distribution Channel
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Consumer
15.4.2.2. By Product
15.4.2.3. By Application
15.4.2.4. By Distribution Channel
15.5. United Kingdom
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Consumer
15.5.2.2. By Product
15.5.2.3. By Application
15.5.2.4. By Distribution Channel
15.6. Spain
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Consumer
15.6.2.2. By Product
15.6.2.3. By Application
15.6.2.4. By Distribution Channel
15.7. Germany
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Consumer
15.7.2.2. By Product
15.7.2.3. By Application
15.7.2.4. By Distribution Channel
15.8. Italy
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Consumer
15.8.2.2. By Product
15.8.2.3. By Application
15.8.2.4. By Distribution Channel
15.9. France
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Consumer
15.9.2.2. By Product
15.9.2.3. By Application
15.9.2.4. By Distribution Channel
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Consumer
15.10.2.2. By Product
15.10.2.3. By Application
15.10.2.4. By Distribution Channel
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Consumer
15.11.2.2. By Product
15.11.2.3. By Application
15.11.2.4. By Distribution Channel
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Consumer
15.12.2.2. By Product
15.12.2.3. By Application
15.12.2.4. By Distribution Channel
15.13. Australia & New Zealand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Consumer
15.13.2.2. By Product
15.13.2.3. By Application
15.13.2.4. By Distribution Channel
15.14. South Africa
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Consumer
15.14.2.2. By Product
15.14.2.3. By Application
15.14.2.4. By Distribution Channel
15.15. GCC Countries
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Consumer
15.15.2.2. By Product
15.15.2.3. By Application
15.15.2.4. By Distribution Channel
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Consumer
16.3.3. By Product
16.3.4. By Application
16.3.5. By Distribution Channel
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Abbott Laboratories
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. B Braun Melsungen AG
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Baxter International Inc
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. Fresenius Kabi
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Mead Johnson
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Nestle Health Science
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Perrigo Co.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Pfizer, Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Danone
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Hero Nutritionals Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Healthcare
June 2024
REP-GB-14775
250 pages
Explore Healthcare Insights
View Reports
Clinical Nutrition Market
